Solventum Corp | SOLV - Operating Expenses

Stock Price
68.52
Daily Change
-0.44 -0.64%
Monthly
6.00%
Yearly
3.71%
Q2 Forecast
67.05

Solventum Corp reported $1.89B in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Abbott USD 9.31B 104M Mar/2026
Align Technology USD 822.85M 11.8M Dec/2025
Baxter International USD 3.19B 554.4M Dec/2025
Becton, Dickinson and Co. USD 4.59B 476M Dec/2025
Cencora USD 84.92B 2.15B Dec/2025
Dexcom USD 936.6M 30.2M Dec/2025
Insulet USD 637.5M 48.9M Dec/2025
Solventum Corp USD 1.89B 3.09B Dec/2025
West Pharmaceutical Services USD 2.99B 2.35B Mar/2026
Zimmer Biomet Holdings USD 1.94B 277.8M Dec/2025